Last updated: January 27, 2023
Sponsor: Zhejiang Chinese Medical University
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Depression
Mood Disorders
Depression (Major/severe)
Treatment
N/AClinical Study ID
NCT05144880
2020YKJ08
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients suffering from MDD in accordance with the diagnostic criteria;
- Hamilton Depression Scale score is between 21 and 35 (mild to moderate MDD);
- 18≤age≤60 years, both gender;
- Patients who have not used antidepressants and other psychiatric drugs (includingtraditional Chinese medicine), or have used them but have stopped for at least 2weeks;
- Patients have clear consciousness and could communicate with others normally;
- Patients could understand the full study protocol and written informed consent isprovided by themselves. Note: Subjects who meet the above six items will be included.
Exclusion
Exclusion Criteria:
- Patients with bipolar disorder;
- Patients with schizophrenia or other mental disorders;
- Patients with severe medical diseases, tumors or diseases of the central nervoussystem;
- Patients suffering from severe depressive episode with psychotic symptoms;
- Suicidal patients;
- Patients with seasonal depression;
- Patients with organic depression;
- Patients with alcohol or drug addicts;
- Patients using other therapies;
- Patients in pregnancy or lactation;
- Patients suffering from cognitive dysfunction, aphasia or other diseases that cannotcooperate with treatment;
- Patients with pacemakers;
- Patients who are not suitable for electroacupuncture.
Study Design
Total Participants: 110
Study Start date:
November 01, 2021
Estimated Completion Date:
December 30, 2024
Connect with a study center
Xiaoyu Li
Hangzhou, Zhejiang 310053
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.